Financial Performance - Q1 2024 revenue was 201.4million,adecreaseof1.1203.5 million) and a decrease of 10.8% from Q1 2023 (225.9million)[2]−Q12024GAAPgrossmarginwas11.49.0 million, an improvement from a net loss of 11.9millioninQ42023andanetincomeof0.0 million in Q1 2023 [2] - Q1 2024 diluted EPS was (0.30),comparedto(0.40) in Q4 2023 and 0.00inQ12023[2]−Non−GAAPnetlossforQ12024was(2.7) million, compared to (1.7)millioninQ42023and11.1 million in Q1 2023 [3] - Operating loss for the three months ended March 29, 2024, was 3.7million,animprovementfromalossof8.0 million in the previous quarter [32] - U.S. GAAP net loss for Q1 2024 was 8.989million,animprovementfromalossof11.899 million in Q4 2023 [36] - Non-GAAP net loss for Q1 2024 was 2.712million,comparedtoalossof1.675 million in Q4 2023 and a profit of 11.128millioninQ12023[36]−Non−GAAPoperatingincomeforthethreemonthsendedMarch29,2024,was2.4 million, compared to 13.7millioninthesameperiodlastyear[32]−U.S.GAAPdilutedEPSforQ12024was(0.30), improving from (0.40)inQ42023[36]−Non−GAAPdilutedEPSforQ12024was(0.09), slightly worse than (0.06)inQ42023[36]CashFlowandLiquidity−CashandcashequivalentsattheendofQ12024were102.1 million, an increase of 22.2millionfromtheprioryear[6]−CashprovidedbyoperatingactivitiesinQ12024was4.8 million, consisting of a net loss of 9.0millionandnetnon−cashchargesof10.2 million [8] - Net cash provided by operating activities for Q1 2024 was 4.804million,downfrom37.574 million in Q4 2023 [38] - Free cash flow for Q1 2024 was 314thousand,asignificantdecreasefrom35.317 million in Q4 2023 [38] - Cash and cash equivalents increased to 102.1millionasofMarch29,2024,upfrom80.0 million at the end of the previous quarter [27] Debt and Assets - The company reduced total debt outstanding by 117millionattheendofQ12024[3]−Totalcurrentassetsroseto421.2 million, compared to 401.4millioninthepreviousquarter[23]−Totalliabilitiesdecreasedsignificantlyto260.2 million from 373.8millioninthepreviousquarter[23]−Thecompanyissuedordinaryshares,netoffees,amountingto136.7 million during the quarter [27] Expenses and Investments - Research and development expenses for the three months ended March 29, 2024, were 5.4million,slightlydownfrom5.5 million in the previous quarter [25] - Capital expenditures in Q1 2024 were 4.490million,comparedto2.257 million in Q4 2023 [38] - Share-based compensation expenses were 2.375millioninQ12024,downfrom4.672 million in Q4 2023 [36] - The company incurred transaction-related costs of 785thousandinQ12024relatedtoacquisitions[36]FutureOutlook−ForQ22024,thecompanyexpectsrevenuetobeintherangeof190 million to 205millionandGAAPdilutedEPStobebetween(0.22) and $(0.10) [4] - The company aims to deepen and expand its penetration of proprietary products in the semiconductor capital equipment market [1] Valuation and Tax - The company recorded a valuation allowance against U.S. federal and state deferred tax assets starting Q1 2024 [37]